...
首页> 外文期刊>Annals of nuclear medicine >Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT
【24h】

Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT

机译:用脑灌注SPECT验证具有优化比率的优化比例,以诱导阿尔茨海默病的患有石油症的痴呆症

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective Dementia with Lewy bodies (DLB) is often cited as the second most common dementia after Alzheimer's disease (AD). It is clinically important to distinguish DLB from AD because specific side effects of antipsychotic drugs are limited to DLB. The relative preservation of cingulate glucose metabolism in the posterior cingulate gyri versus that in the precuni, known as the cingulate island sign (CIS), in patients with DLB compared with AD is supposed to be highly specific for diagnosing DLB. In a previous study, using brain perfusion SPECT, the largest value (0.873) for the area under the receiver operating characteristic (ROC) curve (AUC) for differentiating DLB from AD was obtained with the ratio of the posterior cingulate gyri from an early Alzheimer's disease-specific hypoperfusion volume of interest (VOI) versus the medial occipital lobe. Two purposes of this study are as follows: one is optimization of VOI setting for calculating CIS values and the other is to evaluate their accuracy and simultaneously to retest the method described in our previous paper.
机译:具有Lewy尸体(DLB)的客观痴呆通常被称为阿尔茨海默病(AD)后的第二个最常见的痴呆症。在临床上是重要的,因为抗精神病药物的特定副作用限于DLB,因此可以从AD中区分DLB。在DLB患者与AD相比,DLB患者中,在后刺胰蛋白中,在后刺血管术中的相对保存在DLB患者中,患者被称为刺痛岛符号(CIS)。应该是诊断DLB的高度特异性。在先前的研究中,利用脑灌注SPECT,通过早期的阿尔茨海默氏菌属的比率获得用于区分从AD的接收器操作特性(ROC)曲线(AUC)下区域的最大值(0.873)。感兴趣的疾病特异性低渗量(VOI)与内侧枕叶。本研究的两个目的如下:一个是用于计算CIS值的VOI设置,另一个是评估其准确性并同时重新测试我们之前纸张中描述的方法。

著录项

  • 来源
    《Annals of nuclear medicine》 |2017年第7期|共8页
  • 作者单位

    Natl Ctr Neurol &

    Psychiat Integrat Brain Imaging Ctr 4-1-1 Ogawahigashi Kodaira Tokyo 1878551;

    FUJIFILM RI Pharma Co Ltd QMS Grp Qual Assurance Dept Chuo Ku 14-1 Kyobashi 2 Chome Tokyo;

    Natl Ctr Neurol &

    Psychiat Integrat Brain Imaging Ctr 4-1-1 Ogawahigashi Kodaira Tokyo 1878551;

    Natl Ctr Neurol &

    Psychiat Dept Neurol 4-1-1 Ogawahigashi Kodaira Tokyo 1878551 Japan;

    Natl Ctr Neurol &

    Psychiat Dept Radiol 4-1-1 Ogawahigashi Kodaira Tokyo 1878551 Japan;

    Natl Ctr Neurol &

    Psychiat Dept Radiol 4-1-1 Ogawahigashi Kodaira Tokyo 1878551 Japan;

    Natl Ctr Neurol &

    Psychiat Dept Neurol 4-1-1 Ogawahigashi Kodaira Tokyo 1878551 Japan;

    Natl Ctr Neurol &

    Psychiat Integrat Brain Imaging Ctr 4-1-1 Ogawahigashi Kodaira Tokyo 1878551;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 放射医学;
  • 关键词

    Brain perfusion SPECT; CIS; DLB; Alzheimer's disease;

    机译:脑灌注SPECT;CIS;DLB;阿尔茨海默病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号